Inogen, Inc. (INGN)
| Market Cap | 751.71M |
| Revenue (ttm) | 355.58M |
| Net Income (ttm) | 11.42M |
| Shares Out | 22.72M |
| EPS (ttm) | 0.50 |
| PE Ratio | 65.77 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 121,154 |
| Open | 32.35 |
| Previous Close | 32.39 |
| Day's Range | 31.86 - 33.52 |
| 52-Week Range | 29.28 - 82.35 |
| Beta | 0.94 |
| Analysts | Hold |
| Price Target | 42.33 (+28.0%) |
| Earnings Date | Nov 4, 2021 |
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat...
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for Inogen stock is "Hold." The 12-month stock price forecast is 42.33, which is an increase of 27.96% from the latest price.
News
Inogen (INGN) Earnings and Revenues Surpass Estimates in Q3
Inogen's (INGN) third-quarter results benefit from higher revenues across its segments.
Inogen (INGN) Q3 Earnings and Revenues Surpass Estimates
Inogen (INGN) delivered earnings and revenue surprises of 282.76% and 9.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Inogen Announces Third Quarter 2021 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...
Inogen Announces Participation in the Stifel Virtual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...
Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third ...
Inogen Appoints Stanislav Glezer as Chief Technology Officer
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today an...
Here's Why You Should Retain Inogen (INGN) Stock For Now
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen Strengthens Commercial Capabilities Through New Ashfield Relationship
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today an...
Inogen (INGN) Stock Loses 26.7% In Spite of Q2 Earnings Beat
Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.
Inogen Stock Plunges As Supply Chain Constraints Pile Up To Hit 2H FY21; Analysts Downgrade Stock
Inogen Inc (NASDAQ: INGN) reported Q2 revenue of $101.6 million, +41.7% Y/Y, beating the consensus of $88.75 million. The sales growth was driven primarily due to strong consumer demand, improved averag...
Inogen (INGN) Q2 Earnings and Revenues Beat Estimates
Inogen (INGN) delivered earnings and revenue surprises of 269.23% and 15.22%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Inogen: Q2 Earnings Insights
Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 83.33% over the past year to $0.22, which beat the estim...
Inogen Announces Second Quarter 2021 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...
Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second...
Inogen (INGN) Hits New 52-Week High: What's Driving It?
Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.
Top Ranked Momentum Stocks to Buy for June 29th
Top Ranked Momentum Stocks to Buy for June 29th
Here's Why You Should Add Inogen (INGN) to Your Portfolio
Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.
Inogen Announces Appointment of General Counsel
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...
Inogen Announces Appointment of Chief Medical Officer
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...
Inogen (INGN) Down 11.5% Since Last Earnings Report: Can It Rebound?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
Inogen Strengthens Board of Directors with Addition of Elizabeth Mora
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth)...
Inogen Announces Participation in the 41st Annual William Blair Virtual Growth Stock Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...
Inogen (INGN) Q1 Loss Narrower Than Expected, Revenues Beat
Inogen (INGN) gains traction from revenue growth within its Rental segment in Q1.
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 89.29% and 8.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?